David Y. Thomas
McGill University
H-index: 98
North America-Canada
Top articles of David Y. Thomas
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Treatment | 2022/12/1 | ||
Ionocyte-Specific Regulation of Cystic Fibrosis Transmembrane Conductance Regulator | American Journal of Respiratory Cell & Molecular Biology | Yukiko Sato Dusik Kim Mark J Turner Yishan Luo Zehra Zaidi | 2023/9/1 |
N‐glycosylation mediated folding and quality control in serine proteases of the hepsin family | The FEBS Journal | John JM Bergeron David Y Thomas | 2023/8 |
The NSAID glafenine rescues class 2 CFTR mutants via cyclooxygenase 2 inhibition of the arachidonic acid pathway | Scientific reports | Graeme W Carlile Qi Yang Elizabeth Matthes Jie Liao Véronique Birault | 2022/3/17 |
Rescue of mutant CFTR trafficking defect by the investigational compound MCG1516A | Cells | Miquéias Lopes-Pacheco Mafalda Bacalhau Sofia S Ramalho Iris AL Silva Filipa C Ferreira | 2022/1/1 |
Chronic obstructive pulmonary disease and the modulation of CFTR by acute exposure to cigarette smoke | John W Hanrahan Asmahan Abu-Arish Francis H Wong Mark J Turner Graeme W Carlile | 2022/11/1 | |
Macrocycle-stabilization of its interaction with 14-3-3 increases plasma membrane localization and activity of CFTR | Nature Communications | Loes M Stevers Madita Wolter Graeme W Carlile Dwight Macdonald Luc Richard | 2022/6/23 |
Cyclic nucleotide phosphodiesterase inhibitors as therapeutic interventions for cystic fibrosis | Mark J Turner Kathy Abbott-Banner David Y Thomas John W Hanrahan | 2021/8/1 | |
Nonspecific binding of common anti-CFTR antibodies in ciliated cells of human airway epithelium | Scientific Reports | Yukiko Sato Kamila R Mustafina Yishan Luo Carolina Martini David Y Thomas | 2021/12/1 |
Phosphodiesterase 8A regulates CFTR activity in airway epithelial cells | Cell Physiol. Biochem | Mark J Turner Yukiko Sato David Y Thomas Kathy Abbott-Banner John W Hanrahan | 2021/12/1 |
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer | Leukemia | Deepak Singhal Christopher N Hahn Simone Feurstein Li Yan A Wee Luke Moma | 2021/11 |
Alternative splicing of a receptor intracellular domain yields different ectodomain conformations, enabling isoform-selective functional ligands | Iscience | Fouad Brahimi Alba Galan Sean Jmaeff Pablo F Barcelona Nicolas De Jay | 2020/9/25 |
The dual phosphodiesterase 3/4 inhibitor RPL554 stimulates rare class III and IV CFTR mutants | American Journal of Physiology-Lung Cellular and Molecular Physiology | Mark J Turner Yishan Luo David Y Thomas John W Hanrahan | 2020/5/1 |
Characterization of the mechanism of action of RDR01752, a novel corrector of F508del-CFTR | Biochemical Pharmacology | Miquéias Lopes-Pacheco Iris AL Silva Mark J Turner Graeme W Carlile Elvira Sondo | 2020/10/1 |
Combination of selective PARP3 and PARP16 inhibitory analogues of latonduine a corrects F508del-CFTR Trafficking | ACS omega | Ryan M Centko Graeme W Carlile Isabel Barne Brian O Patrick Polina Blagojevic | 2020/9/29 |
